Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Diabetes is a global epidemic affecting an estimated 382 million people worldwide. The WHO projects that diabetes will be the 7th leading cause of death by 2030. An estimated 4 million people die annually from the complications associated with diabetes. Therefore, if the current trend associated with the prevalence of diabetes continues over the coming years, the number of diabetic patients across the globe would be tremendous after a decade.
The global Diabetic Lancing Device market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Diabetic Lancing Device in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Diabetic Lancing Device market. Push Button Safety Lancets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Pressure Activated Safety Lancets segment is estimated at % CAGR for the next seven-year period.
Increasing prevalence of diabetes will result in the rising demand for devices and products to monitor and control diabetes, eventually leading to increased consumption of lancets. Thus, the demand for lancets is expected to be enormous in the coming future.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diabetic Lancing Device, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diabetic Lancing Device market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diabetic Lancing Device market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diabetic Lancing Device sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diabetic Lancing Device covered in this report include B. Braun, Terumo Corporation, Becton Dickinson, Sanofi, Roche, Bayer, Novo Nordisk, Eli Lilly and Medtronic, etc.
The global Diabetic Lancing Device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Global Diabetic Lancing Device market, by region:
Global Diabetic Lancing Device market, Segment by Type:
Global Diabetic Lancing Device market, by Application:
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Diabetic Lancing Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Diabetic Lancing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Diabetic Lancing Device Market Overview
1.1 Diabetic Lancing Device Product Overview
1.2 Diabetic Lancing Device Market Segment by Type
1.2.1 Push Button Safety Lancets
1.2.2 Pressure Activated Safety Lancets
1.2.3 Side Button Safety Lancets
1.3 Global Diabetic Lancing Device Market Size by Type
1.3.1 Global Diabetic Lancing Device Market Size Overview by Type (2018-2029)
1.3.2 Global Diabetic Lancing Device Historic Market Size Review by Type (2018-2023)
1.3.3 Global Diabetic Lancing Device Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Diabetic Lancing Device Sales Breakdown by Type (2018-2023)
1.4.2 Europe Diabetic Lancing Device Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Diabetic Lancing Device Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Diabetic Lancing Device Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Diabetic Lancing Device Sales Breakdown by Type (2018-2023)
2 Global Diabetic Lancing Device Market Competition by Company
2.1 Global Top Players by Diabetic Lancing Device Sales (2018-2023)
2.2 Global Top Players by Diabetic Lancing Device Revenue (2018-2023)
2.3 Global Top Players by Diabetic Lancing Device Price (2018-2023)
2.4 Global Top Manufacturers Diabetic Lancing Device Manufacturing Base Distribution, Sales Area, Product Type
2.5 Diabetic Lancing Device Market Competitive Situation and Trends
2.5.1 Diabetic Lancing Device Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Diabetic Lancing Device Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetic Lancing Device as of 2022)
2.7 Date of Key Manufacturers Enter into Diabetic Lancing Device Market
2.8 Key Manufacturers Diabetic Lancing Device Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Diabetic Lancing Device Status and Outlook by Region
3.1 Global Diabetic Lancing Device Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Diabetic Lancing Device Historic Market Size by Region
3.2.1 Global Diabetic Lancing Device Sales in Volume by Region (2018-2023)
3.2.2 Global Diabetic Lancing Device Sales in Value by Region (2018-2023)
3.2.3 Global Diabetic Lancing Device Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Diabetic Lancing Device Forecasted Market Size by Region
3.3.1 Global Diabetic Lancing Device Sales in Volume by Region (2024-2029)
3.3.2 Global Diabetic Lancing Device Sales in Value by Region (2024-2029)
3.3.3 Global Diabetic Lancing Device Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Diabetic Lancing Device by Application
4.1 Diabetic Lancing Device Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Diabetic Lancing Device Market Size by Application
4.2.1 Global Diabetic Lancing Device Market Size Overview by Application (2018-2029)
4.2.2 Global Diabetic Lancing Device Historic Market Size Review by Application (2018-2023)
4.2.3 Global Diabetic Lancing Device Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Diabetic Lancing Device Sales Breakdown by Application (2018-2023)
4.3.2 Europe Diabetic Lancing Device Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Diabetic Lancing Device Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Diabetic Lancing Device Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Diabetic Lancing Device Sales Breakdown by Application (2018-2023)
5 North America Diabetic Lancing Device by Country
5.1 North America Diabetic Lancing Device Historic Market Size by Country
5.1.1 North America Diabetic Lancing Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Diabetic Lancing Device Sales in Volume by Country (2018-2023)
5.1.3 North America Diabetic Lancing Device Sales in Value by Country (2018-2023)
5.2 North America Diabetic Lancing Device Forecasted Market Size by Country
5.2.1 North America Diabetic Lancing Device Sales in Volume by Country (2024-2029)
5.2.2 North America Diabetic Lancing Device Sales in Value by Country (2024-2029)
6 Europe Diabetic Lancing Device by Country
6.1 Europe Diabetic Lancing Device Historic Market Size by Country
6.1.1 Europe Diabetic Lancing Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Diabetic Lancing Device Sales in Volume by Country (2018-2023)
6.1.3 Europe Diabetic Lancing Device Sales in Value by Country (2018-2023)
6.2 Europe Diabetic Lancing Device Forecasted Market Size by Country
6.2.1 Europe Diabetic Lancing Device Sales in Volume by Country (2024-2029)
6.2.2 Europe Diabetic Lancing Device Sales in Value by Country (2024-2029)
7 Asia-Pacific Diabetic Lancing Device by Region
7.1 Asia-Pacific Diabetic Lancing Device Historic Market Size by Region
7.1.1 Asia-Pacific Diabetic Lancing Device Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Diabetic Lancing Device Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Diabetic Lancing Device Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Diabetic Lancing Device Forecasted Market Size by Region
7.2.1 Asia-Pacific Diabetic Lancing Device Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Diabetic Lancing Device Sales in Value by Region (2024-2029)
8 Latin America Diabetic Lancing Device by Country
8.1 Latin America Diabetic Lancing Device Historic Market Size by Country
8.1.1 Latin America Diabetic Lancing Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Diabetic Lancing Device Sales in Volume by Country (2018-2023)
8.1.3 Latin America Diabetic Lancing Device Sales in Value by Country (2018-2023)
8.2 Latin America Diabetic Lancing Device Forecasted Market Size by Country
8.2.1 Latin America Diabetic Lancing Device Sales in Volume by Country (2024-2029)
8.2.2 Latin America Diabetic Lancing Device Sales in Value by Country (2024-2029)
9 Middle East and Africa Diabetic Lancing Device by Country
9.1 Middle East and Africa Diabetic Lancing Device Historic Market Size by Country
9.1.1 Middle East and Africa Diabetic Lancing Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Diabetic Lancing Device Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Diabetic Lancing Device Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Diabetic Lancing Device Forecasted Market Size by Country
9.2.1 Middle East and Africa Diabetic Lancing Device Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Diabetic Lancing Device Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 B. Braun
10.1.1 B. Braun Company Information
10.1.2 B. Braun Introduction and Business Overview
10.1.3 B. Braun Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.1.4 B. Braun Diabetic Lancing Device Products Offered
10.1.5 B. Braun Recent Development
10.2 Terumo Corporation
10.2.1 Terumo Corporation Company Information
10.2.2 Terumo Corporation Introduction and Business Overview
10.2.3 Terumo Corporation Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Terumo Corporation Diabetic Lancing Device Products Offered
10.2.5 Terumo Corporation Recent Development
10.3 Becton Dickinson
10.3.1 Becton Dickinson Company Information
10.3.2 Becton Dickinson Introduction and Business Overview
10.3.3 Becton Dickinson Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Becton Dickinson Diabetic Lancing Device Products Offered
10.3.5 Becton Dickinson Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Diabetic Lancing Device Products Offered
10.4.5 Sanofi Recent Development
10.5 Roche
10.5.1 Roche Company Information
10.5.2 Roche Introduction and Business Overview
10.5.3 Roche Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Roche Diabetic Lancing Device Products Offered
10.5.5 Roche Recent Development
10.6 Bayer
10.6.1 Bayer Company Information
10.6.2 Bayer Introduction and Business Overview
10.6.3 Bayer Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bayer Diabetic Lancing Device Products Offered
10.6.5 Bayer Recent Development
10.7 Novo Nordisk
10.7.1 Novo Nordisk Company Information
10.7.2 Novo Nordisk Introduction and Business Overview
10.7.3 Novo Nordisk Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Novo Nordisk Diabetic Lancing Device Products Offered
10.7.5 Novo Nordisk Recent Development
10.8 Eli Lilly
10.8.1 Eli Lilly Company Information
10.8.2 Eli Lilly Introduction and Business Overview
10.8.3 Eli Lilly Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Eli Lilly Diabetic Lancing Device Products Offered
10.8.5 Eli Lilly Recent Development
10.9 Medtronic
10.9.1 Medtronic Company Information
10.9.2 Medtronic Introduction and Business Overview
10.9.3 Medtronic Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Medtronic Diabetic Lancing Device Products Offered
10.9.5 Medtronic Recent Development
10.10 Ypsomed Holding
10.10.1 Ypsomed Holding Company Information
10.10.2 Ypsomed Holding Introduction and Business Overview
10.10.3 Ypsomed Holding Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Ypsomed Holding Diabetic Lancing Device Products Offered
10.10.5 Ypsomed Holding Recent Development
10.11 Sarstedt
10.11.1 Sarstedt Company Information
10.11.2 Sarstedt Introduction and Business Overview
10.11.3 Sarstedt Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Sarstedt Diabetic Lancing Device Products Offered
10.11.5 Sarstedt Recent Development
10.12 Abbott Laboratories
10.12.1 Abbott Laboratories Company Information
10.12.2 Abbott Laboratories Introduction and Business Overview
10.12.3 Abbott Laboratories Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Abbott Laboratories Diabetic Lancing Device Products Offered
10.12.5 Abbott Laboratories Recent Development
10.13 HTL-STREFA
10.13.1 HTL-STREFA Company Information
10.13.2 HTL-STREFA Introduction and Business Overview
10.13.3 HTL-STREFA Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.13.4 HTL-STREFA Diabetic Lancing Device Products Offered
10.13.5 HTL-STREFA Recent Development
10.14 Improve Medical
10.14.1 Improve Medical Company Information
10.14.2 Improve Medical Introduction and Business Overview
10.14.3 Improve Medical Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Improve Medical Diabetic Lancing Device Products Offered
10.14.5 Improve Medical Recent Development
10.15 UltiMed
10.15.1 UltiMed Company Information
10.15.2 UltiMed Introduction and Business Overview
10.15.3 UltiMed Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.15.4 UltiMed Diabetic Lancing Device Products Offered
10.15.5 UltiMed Recent Development
10.16 Allison Medical
10.16.1 Allison Medical Company Information
10.16.2 Allison Medical Introduction and Business Overview
10.16.3 Allison Medical Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Allison Medical Diabetic Lancing Device Products Offered
10.16.5 Allison Medical Recent Development
10.17 Artsana
10.17.1 Artsana Company Information
10.17.2 Artsana Introduction and Business Overview
10.17.3 Artsana Diabetic Lancing Device Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Artsana Diabetic Lancing Device Products Offered
10.17.5 Artsana Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Diabetic Lancing Device Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Diabetic Lancing Device Industrial Chain Analysis
11.4 Diabetic Lancing Device Market Dynamics
11.4.1 Diabetic Lancing Device Industry Trends
11.4.2 Diabetic Lancing Device Market Drivers
11.4.3 Diabetic Lancing Device Market Challenges
11.4.4 Diabetic Lancing Device Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Diabetic Lancing Device Distributors
12.3 Diabetic Lancing Device Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research